Clinical Trial Update: Comparative Effectiveness and Safety of Tiotropium and Olodaterol in Comparison to LABA/ICS

View source ↗

Summary

A completed clinical trial comparing tiotropium and olodaterol against LABA/ICS for COPD, with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• LABA/ICS
• olodaterol (olodaterol)
• tiotropium (tiotropium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: COPD | Status: COMPLETED | Results posted: 2020-11-30